ReCode Therapeutics Announces Scientific Advisory Board and New Scientific Advisor
UTSW’s Daniel Siegwart and Eric Olson [Courtesy photos] ReCode Therapeutics, a genetic drug platform with targeted delivery and pipeline of mRNA and gene correction therapies, announced that it has formed a Scientific Advisory Board and added Scientific Advisor Elliott Sigal, MD, Ph.D. ReCode has offices in Dallas and Menlo Park, California. Chaired by Daniel J. …
ReCode Therapeutics Announces Scientific Advisory Board and New Scientific Advisor Read More »